ATE315389T1 - Ibogamin verwandte verbindungen - Google Patents

Ibogamin verwandte verbindungen

Info

Publication number
ATE315389T1
ATE315389T1 AT96928041T AT96928041T ATE315389T1 AT E315389 T1 ATE315389 T1 AT E315389T1 AT 96928041 T AT96928041 T AT 96928041T AT 96928041 T AT96928041 T AT 96928041T AT E315389 T1 ATE315389 T1 AT E315389T1
Authority
AT
Austria
Prior art keywords
substituted alkyl
unsubstituted
group
alkyl
ibogamine
Prior art date
Application number
AT96928041T
Other languages
English (en)
Inventor
Stanley D Glick
Martin E Kuehne
Original Assignee
Albany Medical College
Univ Vermont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Medical College, Univ Vermont filed Critical Albany Medical College
Application granted granted Critical
Publication of ATE315389T1 publication Critical patent/ATE315389T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glass Compositions (AREA)
  • Executing Machine-Instructions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
AT96928041T 1995-08-08 1996-08-02 Ibogamin verwandte verbindungen ATE315389T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US204895P 1995-08-08 1995-08-08

Publications (1)

Publication Number Publication Date
ATE315389T1 true ATE315389T1 (de) 2006-02-15

Family

ID=21699020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928041T ATE315389T1 (de) 1995-08-08 1996-08-02 Ibogamin verwandte verbindungen

Country Status (6)

Country Link
US (1) US6211360B1 (de)
EP (1) EP0859610B1 (de)
AT (1) ATE315389T1 (de)
DE (1) DE69635737D1 (de)
IL (1) IL123220A0 (de)
WO (1) WO1997005869A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780871B2 (en) 2001-01-29 2004-08-24 Albany Medical College Methods and compositions for treating addiction disorders
BR0106261A (pt) * 2001-12-26 2003-09-02 Fundacao Oswaldo Cruz Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
US20050251442A1 (en) * 2004-05-07 2005-11-10 Joseph Ficalora Consumer incentive system and business method
PT2244572T (pt) * 2008-01-28 2016-07-14 Albany Medical College Utilização de congéneres de ibogamina para tratar obesidade
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
CA2806232A1 (en) 2010-07-23 2012-01-26 Demerx, Inc. Noribogaine compositions
EP2481740B1 (de) * 2011-01-26 2015-11-04 DemeRx, Inc. Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
US8742096B2 (en) 2011-03-28 2014-06-03 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
EP2788356A4 (de) * 2011-12-09 2015-10-21 Demerx Inc Sulfatester aus noribogain
CA2855994A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US20130178618A1 (en) 2012-01-10 2013-07-11 William Allen Boulanger Novel pharmaceutical intermediates and methods for preparing the same
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
WO2013148572A1 (en) * 2012-03-27 2013-10-03 Albany Medical College Blocking of cue-induced drug reinstatement
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
CA2896133A1 (en) * 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US10939822B2 (en) 2013-01-24 2021-03-09 Tylerton International Holdings Inc. Body structure imaging
EP2948188B1 (de) 2013-01-24 2021-09-08 Tylerton International Holdings Inc. Neuronale bildgebung und behandlung
WO2015033317A2 (en) 2013-09-08 2015-03-12 Shlomo Ben-Haim Detection of reduced-control cardiac zones
CN106102583B (zh) 2014-01-10 2024-08-09 泰勒顿国际控股公司 瘢痕和纤维心脏区的检测
WO2015195673A2 (en) 2014-06-18 2015-12-23 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
EP3174466B1 (de) 2014-07-30 2020-06-17 Navix International Limited Sondenlokalisierung
US12564597B2 (en) 2020-03-05 2026-03-03 The Trustees Of Columbia University In The Of New York Ibogaine analogs as therapeutics for neurological and psychiatric disorders
US11680066B2 (en) * 2020-05-18 2023-06-20 Jeffrey Alan McKinney Ibogaine-related compounds and corresponding methods
US12116372B1 (en) 2023-12-14 2024-10-15 William Allen Boulanger Process for preparing methyl 3-bromo-2-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)propanoate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH434281A (de) * 1964-03-04 1967-04-30 Geigy Ag J R Verfahren zur Herstellung von polycyclischen Indolderivaten
US3681362A (en) * 1968-06-29 1972-08-01 Shionogi & Co Process for the preparation of isoquinuclidine alkaloids
GB1445287A (en) * 1973-10-24 1976-08-11 Omnium Chimique Sa Derivatives of iboga type alkaloids
FR2296418B1 (de) * 1974-12-30 1978-07-21 Anvar
US4499096A (en) * 1983-11-18 1985-02-12 Lotsof Howard S Rapid method for interrupting the narcotic addiction syndrome
US4587243A (en) 1985-07-15 1986-05-06 Lotsof Howard S Rapid method for interrupting the cocaine and amphetamine abuse syndrome
JPH0341081A (ja) * 1989-07-10 1991-02-21 Mitsui Petrochem Ind Ltd 二量体アルカロイド類の製造方法
US5152994A (en) * 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
JPH0559053A (ja) * 1991-02-28 1993-03-09 Mikio Yamazaki インドールアルカロイド化合物

Also Published As

Publication number Publication date
EP0859610B1 (de) 2006-01-11
WO1997005869A1 (en) 1997-02-20
EP0859610A4 (de) 2002-05-15
US6211360B1 (en) 2001-04-03
DE69635737D1 (de) 2006-04-06
EP0859610A1 (de) 1998-08-26
IL123220A0 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
ATE315389T1 (de) Ibogamin verwandte verbindungen
CA2345297A1 (en) Synthetic analogs of ecteinascidin-743
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
TW369526B (en) Diazabicyclic neurokinin antagonists
MY108885A (en) Heterocyclic-cyclic amine derivatives.
FI941212A0 (fi) Fuusioituneet trisykliset, typpeä sisältävät heterosykliset yhdisteet
ATE209186T1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
PT715628E (pt) Compostos de azaindolilideno substituidos e o seu processo de preparacao
MX9206499A (es) Derivados de etilendiamina aciclica
PT760664E (pt) Utilizacao de derivados de pteridina como inibidores da sintetase de no
DK1000035T3 (da) Substituerede 6-phenylphenanthridiner
FI970147A0 (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
DK0561941T3 (da) N-Substituerede lactamer anvendelige som cholecystokinin-antagonister
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
TR200102524T2 (tr) Dihetero sübstitüe edilmiş metaloproteaz inhibitörleri.
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
ES2133331T3 (es) Pirrolo-piridazinas con efectos protectores del estomago y de los intestinos.
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
FI953784A0 (fi) 3'-atsiridinoantrasykliinijohdannaiset
DE69431471D1 (de) Amide derivate als 5-ht1a liganden
ATE204878T1 (de) Therapeutische verbindungen
WO2009097259A3 (en) Use of ibogamine congeners for treating obesity
IL104657A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties